Basic Information
Ureka is a subsidiary of ImmuPharma. The company is dedicated to developing Urelix technology, which mimics natural peptides (short chains of amino acids). It first focuses on replicating GLP-1, a key peptide in diabetes.
Ureka
United Kingdom
unclear
--
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios